Monthly Archives: January 2015

Do cells remain viable during longterm low temperature storage?

  |
obesity
Development of regenerative and reproductive medicine, increase of the level of insurance culture and a more conscious attitude of modern people to their health led to the high popularity of biobanks worldwide.
Biobanks are medical institutions that are engaged in long-term storage and cryopreservation of biological material under...
Read more

Do cells remain viable during longterm low temperature storage?

  |
obesityDevelopment of regenerative and reproductive medicine, increase of the level of insurance culture and a more conscious attitude of modern people to their health led to the high popularity of biobanks worldwide.
Biobanks are medical institutions that are engaged in long-term storage and cryopreservation of biological material under conditions of the ultra-low temperatures. Frozen cells and tissues in the...
Read more

EU’s First Stem Cell Medicine Recommended by EMA

  |
emea_strap_url_cmyk_rev_en_std_cent.eps MASTERA major milestone in stem cell therapy was reached in December 2014 when a European Medicines Agency (EMA) committee recommended the conditional approval of Holoclar, the first stem-cell product to be recommended for approval in the EU. Holocloar, developed by Chiesi Farmaceutici S.p.A. and Holostem Terapie Avanzate, is an advanced-therapy medicinal product (ATMP) granted orphan designation for...
Read more

Report on the activity of Association of cryobanks in 2014

  |
logoAssociation of cryobanks of umbilical cord blood, other human tissues and cells is the only one of its kind international professional association of licensed enterprises, cryobanks, scientific and educational centers, and clinics operating in the field of biotechnology.
Established in 2013 with a view to the harmonious development of the industry of banking and clinical application of human cells and...
Read more